[Primary bladder lymphoma in kidney transplant recipients: report of a case].
The authors report the case of a type B EBC (+) primary lymphoma of the bladder occurring in a renal transplant patient 14 months after the graft. The postoperative course had been marked by three episodes of early rejection, the last of which required the use of anti-CD3 antibody, then the later addition of cyclosporin. After immune labelling showing oligoclonal proliferation, the lesion was treated with CD24 and CD21 monoclonal antibodies. Ten months after treatment, the patient is in remission with renal function at 200 mumol plasma creatinine. Azathioprine and cyclosporin have been stopped. This apparently unique case provides the authors with an opportunity to review the usual characteristics of lymphocyte tumours in transplant patients and to stress the rarity of primary lesions of the urinary tract. They conclude that the new therapeutic approach based upon monoclonal antibodies is of value in comparison with the attempts at surgery, radiotherapy and/or chemotherapy used in the past.
Bitker
M O
MO
Clinique Urologique de la Pitié, Paris.
Bagnis
C
C
Mouquet
C
C
Rudelle
E
E
Laradi
A
A
Leblond
V
V
Benalia
H
H
Luciani
J
J
Chatelain
C
C
D000328:Adult; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D016393:Lymphoma, B-Cell / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000209:etiology*
Lymphome primitif vésical chez le transplanté rénal: à propos d'un cas.